Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Griguolo

Showing results (11-20 of 131) with videos related to

Pageof 14
Sort By:
Physical Review Letters|May 16, 1994
Lightlike Wilson loops and gauge invariance of Yang-Mills theory in 1+1 dimensionsBassetto, De Biasio F, Griguolo
Physical Review Letters|November 18, 1996
Anyons and Chiral Solitons on a LineAglietti, Griguolo, Jackiw, et al.
Physical Review Letters|March 7, 2025
Supersymmetric Localization and Nonconformal N=2 Supersymmetric Yang-Mills Theories in the Perturbative RegimeMarco Billò, Luca Griguolo, Alessandro Testa
Physical Review Letters|June 17, 2022
Exact TT[over ¯] Deformation of Two-Dimensional Maxwell TheoryLuca Griguolo, Rodolfo Panerai, Jacopo Papalini, et al.
Cancer Treatment Reviews|July 5, 2020
Biomarkers for HER2-positive metastatic breast cancer: Beyond hormone receptorsMaria Vittoria Dieci, Federica Miglietta, Gaia Griguolo, et al.
Expert Review of Anticancer Therapy|March 28, 2018
Olaparib for the treatment of breast cancerGaia Griguolo, Maria Vittoria Dieci, Valentina Guarneri, et al.
Cancer Treatment Reviews|April 8, 2016
The immune system and hormone-receptor positive breast cancer: Is it really a dead end?Maria Vittoria Dieci, Gaia Griguolo, Federica Miglietta, et al.
The Oncologist|August 25, 2019
Programmed Cell Death Ligand 1 in Breast Cancer: Technical Aspects, Prognostic Implications, and Predictive ValueFederica Miglietta, Gaia Griguolo, Valentina Guarneri, et al.
Cancer Treatment Reviews|May 23, 2021
Neoadjuvant approach as a platform for treatment personalization: focus on HER2-positive and triple-negative breast cancerFederica Miglietta, Maria Vittoria Dieci, Gaia Griguolo, et al.
ESMO Open|April 10, 2022
Erratum to 'Major advancements in metastatic breast cancer treatment: when expanding options means prolonging survival': [ESMO Open Volume 7, Issue 2, April 2022, 100409]F Miglietta, M Bottosso, G Griguolo, et al.
Pageof 14

Showing results (11-20 of 131) with videos related to

Sort By:
Pageof 14
Physical Review Letters|May 16, 1994
Lightlike Wilson loops and gauge invariance of Yang-Mills theory in 1+1 dimensionsBassetto, De Biasio F, Griguolo
Physical Review Letters|November 18, 1996
Anyons and Chiral Solitons on a LineAglietti, Griguolo, Jackiw, et al.
Physical Review Letters|March 7, 2025
Supersymmetric Localization and Nonconformal N=2 Supersymmetric Yang-Mills Theories in the Perturbative RegimeMarco Billò, Luca Griguolo, Alessandro Testa
Physical Review Letters|June 17, 2022
Exact TT[over ¯] Deformation of Two-Dimensional Maxwell TheoryLuca Griguolo, Rodolfo Panerai, Jacopo Papalini, et al.
Cancer Treatment Reviews|July 5, 2020
Biomarkers for HER2-positive metastatic breast cancer: Beyond hormone receptorsMaria Vittoria Dieci, Federica Miglietta, Gaia Griguolo, et al.
Expert Review of Anticancer Therapy|March 28, 2018
Olaparib for the treatment of breast cancerGaia Griguolo, Maria Vittoria Dieci, Valentina Guarneri, et al.
Cancer Treatment Reviews|April 8, 2016
The immune system and hormone-receptor positive breast cancer: Is it really a dead end?Maria Vittoria Dieci, Gaia Griguolo, Federica Miglietta, et al.
The Oncologist|August 25, 2019
Programmed Cell Death Ligand 1 in Breast Cancer: Technical Aspects, Prognostic Implications, and Predictive ValueFederica Miglietta, Gaia Griguolo, Valentina Guarneri, et al.
Cancer Treatment Reviews|May 23, 2021
Neoadjuvant approach as a platform for treatment personalization: focus on HER2-positive and triple-negative breast cancerFederica Miglietta, Maria Vittoria Dieci, Gaia Griguolo, et al.
ESMO Open|April 10, 2022
Erratum to 'Major advancements in metastatic breast cancer treatment: when expanding options means prolonging survival': [ESMO Open Volume 7, Issue 2, April 2022, 100409]F Miglietta, M Bottosso, G Griguolo, et al.
Pageof 14